Renal co-morbidity after solid organ transplantation;Renale Ko-Morbidität nach Transplantation solider Organe

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 45, 2012, Pages 2332-2335

  Schiffer, M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chronic kidney disease; heart transplantation; liver transplantation; lung transplantation

Indexed keywords

CHRONIC KIDNEY DISEASE; COMORBIDITY; HEART TRANSPLANTATION; HUMAN; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; ORGAN TRANSPLANTATION; REVIEW;

ACUTE KIDNEY INJURY; AGE FACTORS; CALCINEURIN; COMORBIDITY; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84867897769     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1327253     Document Type: Review

References (44)

1. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol: 2010; 53 397 417
2. Backman L., Reisaeter A. V., Wramner L. et al. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus. Clin Transplant: 2006; 20 336 339 (Pubitemid 43880569)
3. Barri Y. M., Sanchez E. Q., Jennings L. W. et al. Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl: 2009; 15 475 483
4. Bjarnadottir M., Grubb A., Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest: 1995; 55 617 623
5. Bloom R. D., Reese P. P. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol: 2007; 18 3031 3041 (Pubitemid 350223963)
6. Bokenkamp A., van Wijk J. A., Lentze M. J. et al. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem: 2002; 48 1123 1126 (Pubitemid 34680918)
7. Boyer O., Le Bidois J., Dechaux M. et al. Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. Transplantation: 2005; 79 1405 1410 (Pubitemid 40734805)
8. Boyle J. M., Moualla S., Arrigain S. et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis: 2006; 48 787 796 (Pubitemid 44740046)
9. Cabezuelo J. B., Ramirez P., Rios A. et al. Risk factors of acute renal failure after liver transplantation. Kidney Int: 2006; 69 1073 1080 (Pubitemid 43372183)
10. Castroagudin J. F., Molina E., Romero R. et al. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Liver Transpl: 2009; 15 1792 1797
11. Charlton M. R., Wall W. J., Ojo A. O. et al. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl: 2009; 15 1 34
12. Cholongitas E., Shusang V., Marelli L. et al. Review article: renal function assessment in cirrhosis difficulties and alternative measurements. Aliment Pharmacol Ther: 2007; 26 969 978 (Pubitemid 47421959)
13. Clajus C., Hanke N., Gottlieb J. et al. Renal comorbidity after solid organ and stem cell transplantation. Am J Transplant: 2012; 12 1691 1699
14. Creput C., Blandin F., Deroure B. et al. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transpl: 2007; 13 1004 1010 (Pubitemid 47163193)
15. Davis C. L., Feng S., Sung R. et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant: 2007; 7 1702 1709 (Pubitemid 46905445)
16. Fan Y., Xiao Y. B., Weng Y. G. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Transplantation proceedings: 2009; 41 1821 1824
17. Fioretto P., Kim Y., Mauer M. Diabetic nephropathy as a model of reversibility of established renal lesions. Curr Opin Nephrol Hypertens: 1998; 7 489 494 (Pubitemid 28475285)
18. Fioretto P., Steffes M. W., Mihatsch M. J. et al. Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients. Kidney Int: 1995; 48 489 495
19. Fisher N. C., Nightingale P. G., Gunson B. K. et al. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation: 1998; 66 59 66 (Pubitemid 28341169)
20. Flechner S. M. Reviewing the evidence for de novo immunosuppression with sirolimus. Transplant Proc: 2008; 40 25 28
21. Groetzner J., Kaczmarek I., Schulz U. et al. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplantation: 2009; 87 726 733
22. Haas M., Kain R., Mayer G. et al. Heart transplantation or combined heart/kidney transplantation? Even one renal biopsy may fool you. Nephrol Dial Transplant: 1999; 14 1014 1015 (Pubitemid 29155172)
23. Herlenius G., Fistouris J., Olausson M. et al. Early renal function post-liver transplantation is predictive of progressive chronic kidney disease. Scand J Gastroenterol: 2008; 43 344 349 (Pubitemid 351238359)
24. Ishani A., Erturk S., Hertz M. I. et al. Predictors of renal function following lung or heart-lung transplantation. Kidney Int: 2002; 61 2228 2234 (Pubitemid 34539340)
25. Karie-Guigues S., Janus N., Saliba F. et al. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study. Liver Transpl: 2009; 15 1083 1091
26. Kim J. Y., Akalin E., Dikman S. et al. The variable pathology of kidney disease after liver transplantation. Transplantation: 2010; 89 215 221
27. Lindelow B., Bergh C. H., Herlitz H. et al. Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol: 2000; 11 951 957 (Pubitemid 30241731)
28. Mehra M. R., Kobashigawa J., Starling R. et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant: 2006; 25 1024 1042 (Pubitemid 44311532)
29. O'Riordan A., Wong V., McCormick P. A. et al. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant: 2006; 21 2630 2636 (Pubitemid 44644543)
30. Ojo A. O., Held P. J., Port F. K. et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med: 2003; 349 931 940 (Pubitemid 37064766)
31. Orlando R., Mussap M., Plebani M. et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem: 2002; 48 850 858 (Pubitemid 34587584)
32. Poge U., Gerhardt T., Stoffel-Wagner B. et al. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant: 2006; 21 660 664 (Pubitemid 43372911)
33. Risch L., Herklotz R., Blumberg A. et al. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem: 2001; 47 2055 2059 (Pubitemid 33010731)
34. Rocha P. N., Rocha A. T., Palmer S. M. et al. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality. Am J Transplant: 2005; 5 1469 1476 (Pubitemid 40839440)
35. Rothenburger M., Zuckermann A., Bara C. et al. Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference. J Heart Lung Transplant: 2007; 26 305 311 (Pubitemid 46498769)
36. Rubel J. R., Milford E. L., McKay D. B. et al. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant: 2004; 23 289 300 (Pubitemid 38333086)
37. Schlitt H. J., Barkmann A., Boker K. H. et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet: 2001; 357 587 591 (Pubitemid 32179611)
38. Schwarz A., Haller H., Schmitt R. et al. Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Am J Transplant: 2010; 10 2017 2025
39. Shemesh O., Golbetz H., Kriss J. P. et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int: 1985; 28 830 838 (Pubitemid 16156326)
40. Skluzacek P. A., Szewc R. G., Nolan C. R. et al. Prediction of GFR in liver transplant candidates. Am J Kidney Dis: 2003; 42 1169 1176 (Pubitemid 37486760)
41. Soccal P. M., Gasche Y., Favre H. et al. Improvement of drug-induced chronic renal failure in lung transplantation. Transplantation: 1999; 68 164 165 (Pubitemid 29352851)
42. Stevens L. A., Levey A. S. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol: 2009; 20 2305 2313
43. White C. A., Akbari A., Doucette S. et al. Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better? Clinical chemistry: 2010; 56 474 477
44. Wilkinson A., Pham P. T. Kidney dysfunction in the recipients of liver transplants. Liver Transpl: 2005; S47 51 (Pubitemid 43072615)